MX347373B - Soluciones anti-inflamatorias estables para inyección. - Google Patents

Soluciones anti-inflamatorias estables para inyección.

Info

Publication number
MX347373B
MX347373B MX2014001368A MX2014001368A MX347373B MX 347373 B MX347373 B MX 347373B MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 347373 B MX347373 B MX 347373B
Authority
MX
Mexico
Prior art keywords
injection
stable anti
inflammatory
inflammatory solutions
solutions
Prior art date
Application number
MX2014001368A
Other languages
English (en)
Other versions
MX2014001368A (es
Inventor
R Gombotz Wayne
A Demopulos Gregory
Rong Shen Hui
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47627326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX347373(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of MX2014001368A publication Critical patent/MX2014001368A/es
Publication of MX347373B publication Critical patent/MX347373B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente invención se relaciona con formulaciones de líquido estable de ketoprofeno, amitriptilina y oximetazolina.
MX2014001368A 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección. MX347373B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515234P 2011-08-04 2011-08-04
PCT/US2012/049463 WO2013020021A1 (en) 2011-08-04 2012-08-03 Stable anti-inflammatory solutions for injection

Publications (2)

Publication Number Publication Date
MX2014001368A MX2014001368A (es) 2014-06-11
MX347373B true MX347373B (es) 2017-04-25

Family

ID=47627326

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001368A MX347373B (es) 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección.

Country Status (20)

Country Link
US (3) US20130035362A1 (es)
EP (1) EP2739266B1 (es)
JP (2) JP6174579B2 (es)
KR (1) KR101951064B1 (es)
CN (1) CN103957886B (es)
AR (1) AR089203A1 (es)
AU (1) AU2012289968B2 (es)
BR (1) BR112014002631B1 (es)
CA (1) CA2844152C (es)
CL (1) CL2014000267A1 (es)
DK (1) DK2739266T3 (es)
ES (1) ES2600153T3 (es)
IL (1) IL230779B (es)
MX (1) MX347373B (es)
NZ (1) NZ621484A (es)
PL (1) PL2739266T3 (es)
PT (1) PT2739266T (es)
RU (1) RU2635521C2 (es)
WO (1) WO2013020021A1 (es)
ZA (1) ZA201401344B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9636408B2 (en) 2013-03-15 2017-05-02 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
WO2016014408A1 (en) * 2014-07-21 2016-01-28 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US20170049134A1 (en) * 2015-08-18 2017-02-23 Empire Technology Development Llc Meat tendering using food grade natural products for reducing muscle contraction
US20220347122A1 (en) 2019-03-15 2022-11-03 Ftf Pharma Private Limited Solutions for oral dosage
FR3108841B1 (fr) 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
FR3123563B1 (fr) * 2021-06-03 2025-02-14 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
IT1269583B (it) * 1994-04-26 1997-04-08 Bayer Italia Spa Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
MX9703988A (es) * 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
US7091181B2 (en) * 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
EP1881821B1 (en) * 2005-05-20 2016-11-09 Omeros Corporation Compositions comprising ketoprofen and calcium channel antagonist for use in urological procedures
EP1998788A4 (en) * 2006-03-01 2011-08-03 Ruey J Yu COMPOSITIONS AND METHODS FOR THE TOPIC TREATMENT OF DERMATOLOGICAL DISORDERS RESPONSIBLE FOR TAR
CN101677957A (zh) * 2007-02-05 2010-03-24 卡比兰生物外科公司 用于递送生物活性试剂的聚合物制剂
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
ES2742273T3 (es) * 2011-02-15 2020-02-13 Aclaris Therapeutics Inc Composiciones de crema farmacéuticas de oximetazolina para tratar los síntomas de la rosácea

Also Published As

Publication number Publication date
HK1198911A1 (en) 2015-06-19
EP2739266A1 (en) 2014-06-11
DK2739266T3 (en) 2016-10-03
IL230779B (en) 2019-05-30
US20130035362A1 (en) 2013-02-07
BR112014002631B1 (pt) 2022-04-19
IL230779A0 (en) 2014-03-31
RU2635521C2 (ru) 2017-11-13
MX2014001368A (es) 2014-06-11
PT2739266T (pt) 2016-10-04
ES2600153T3 (es) 2017-02-07
CA2844152C (en) 2020-04-14
CA2844152A1 (en) 2013-02-07
PL2739266T3 (pl) 2017-07-31
WO2013020021A1 (en) 2013-02-07
US20180344855A1 (en) 2018-12-06
AR089203A1 (es) 2014-08-06
JP2017014288A (ja) 2017-01-19
AU2012289968A1 (en) 2013-03-28
NZ621484A (en) 2016-05-27
BR112014002631A2 (pt) 2017-03-07
CL2014000267A1 (es) 2014-08-29
EP2739266A4 (en) 2014-12-31
US20160166696A1 (en) 2016-06-16
JP6174579B2 (ja) 2017-08-02
RU2014108159A (ru) 2015-09-10
CN103957886A (zh) 2014-07-30
KR101951064B1 (ko) 2019-02-21
ZA201401344B (en) 2016-10-26
AU2012289968B2 (en) 2014-01-16
KR20140057579A (ko) 2014-05-13
EP2739266B1 (en) 2016-07-27
JP2014521694A (ja) 2014-08-28
CN103957886B (zh) 2016-03-30

Similar Documents

Publication Publication Date Title
EA201590807A1 (ru) Стабильные бесконсервантные мидриатические и противовоспалительные растворы для инъекций
JOP20180103A1 (ar) مركب صيدلاني
UY34587A (es) Formulaciones estabilizadas que contienen anticuerpos antiang2
CL2014003370A1 (es) Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición.
CR20140464A (es) Compuestos de heterociclilo
DK2882850T3 (da) System for preparation of adipose-derived stem cells
MX347373B (es) Soluciones anti-inflamatorias estables para inyección.
CO6852068A2 (es) Formulación líquida estable de etanercept
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
BR112014028334A2 (pt) derivados dipeptídicos de lisina ácido glutâmico.
BR112013025866A2 (pt) formulações com viscosidade reduzida
CO7061076A2 (es) Composición farmacéutica que contiene un derivado de dihidroquinazolina antiviralmente activo
IL236393A0 (en) Stable formulations for parenteral injection of small molecule drugs
PT2931313T (pt) Formulações de solução de anticorpos anti-il-23p19 modificados
CL2016001313A1 (es) Formulaciones listas de fertilizante líquido de bifentrina.
CL2014003059A1 (es) Uso de seaprose para eliminar biopelículas bacterianas; composicion de seaprose.
MX347855B (es) Derivados de anilina, su preparación y su aplicación terapéutica.
BR112015003116A2 (pt) preparação farmacêutica sólida contendo levotiroxina
CL2014002204A1 (es) Formulacion de anticuerpo anti il-17 y sus usos.
CO7151478A2 (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4
IL241245A (en) Bicyclo [2.2.1] acid gpr120 modulators
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
CR20130375A (es) Preparaciones que contienen antraquinona/formulaciones de lignina

Legal Events

Date Code Title Description
FG Grant or registration